Your browser doesn't support javascript.
loading
Survival analysis of acquired immune deficiency syndrome patients with and without hepatitis C virus infection at a reference center for sexually transmitted diseases/acquired immune deficiency syndrome in São Paulo, Brazil
Alencar, Wong Kuen; Duarte, Paulo Schiavom; Waldman, Eliseu Alves.
Afiliación
  • Alencar, Wong Kuen; Centro de Referência e Treinamento DST/AIDS-SP. São Paulo. BR
  • Duarte, Paulo Schiavom; Centro de Referência e Treinamento DST/AIDS-SP. São Paulo. BR
  • Waldman, Eliseu Alves; Centro de Referência e Treinamento DST/AIDS-SP. São Paulo. BR
Braz. j. infect. dis ; Braz. j. infect. dis;18(2): 150-157, Mar-Apr/2014. tab, graf
Article en En | LILACS | ID: lil-709416
Biblioteca responsable: BR1.1
ABSTRACT

INTRODUCTION:

Survival of patients with acquired immune deficiency syndrome has improved with combination antiretroviral therapy; mortality due to liver diseases, however, has also increased in these patients.

OBJECTIVES:

To estimate the accumulated probability of survival in human immunodeficiency virus-hepatitis C virus coinfected and non-coinfected patients and to investigate factors related to acquired immune deficiency syndrome patients' survival.

METHODS:

Non-concurrent cohort study using data from surveillance information systems of acquired immune deficiency syndrome patients over 13 years of age. Hepatitis C and B, human immunodeficiency virus exposure category, CD4+ T cell count, age group, schooling, race, sex, and four acquired immune deficiency syndrome diagnosis periods were studied. Kaplan-Meier survival analysis and Cox model with estimates of the hazard ratio and 95% confidence interval were used.

RESULTS:

Of the total 2864 individuals included, with median age was 35 years, 219 died (7.5%), and 358 (12.5%) were human immunodeficiency virus-hepatitis C virus coinfected. The accumulated probability of survival in human immunodeficiency virus-hepatitis C virus coinfected patients, after acquired immune deficiency syndrome diagnosis, at 120 months, was 0%, 38.9%, 83.8% in 1986-1993, 1994-1996, 1997-2002, respectively, and 92.8% at 96 months in 2003-2010; survival in non-coinfected patients at 120 months was 80%, 90.2%, 94% in 1986-1993, 1994-1996, 1997-2002, respectively, and 94.1% at 96 months in 2003-2010. In the multivariate model the following variables were predictive of death hepatitis C virus coinfection (hazard ratio=2.7; confidence interval 2.0-3.6); Hepatitis B virus coinfection (hazard ratio=2.4; confidence interval 1.7-3.6); being >50 years old (hazard ratio=2.3; confidence interval 1.3-3.8); having 8-11 years of schooling (hazard ratio=1.6; confidence interval 1.1-2.3), having 4-7 years of schooling ...
Asunto(s)
Palabras clave

Texto completo: 1 Índice: LILACS Asunto principal: Síndrome de Inmunodeficiencia Adquirida / Hepatitis C / Coinfección Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: America do sul / Brasil Idioma: En Revista: Braz. j. infect. dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2014 Tipo del documento: Article

Texto completo: 1 Índice: LILACS Asunto principal: Síndrome de Inmunodeficiencia Adquirida / Hepatitis C / Coinfección Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: America do sul / Brasil Idioma: En Revista: Braz. j. infect. dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2014 Tipo del documento: Article